Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Ann Arbor at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
The purpose of this study is to determine safety and preliminary efficacy of amivantamab monotherapy, amivantamab in addition to pembrolizumab, amivantamab in addition to paclitaxel and amivantamab in addition to pembrolizumab and carboplatin in participants with recurrent/metastatic head and neck cancer. The study will also confirm the recommended Phase 2 combination dose (RP2CD) for amivantamab in addition to paclitaxel.
Sponsor: Janssen Research & Development, LLC
Check if you qualify for this head and neck cancer clinical trial in Ann Arbor, MI
If you're searching for head and neck cancer treatment options in Ann Arbor, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Ann Arbor research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.